See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: July 10, 2006

Atrial Fibrillation Prostate Cancer Diabetes - Type 2

(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:

Atrial Fibrillation

This research study is looking at the safety and effectiveness of an investigational drug for individuals with atrial fibrillation.

Successful volunteers should be at leat 18 years old with a documented history of atrial fibrillation. Qualified participants will receive study-related medical care and medication at no cost.

The research site is in Worcester, Mass.

More information

Please see http://www.centerwatch.com/patient/studies/cat243.html.

-----

Prostate Cancer

This is a three-year placebo-controlled study with dutasteride to assess the efficacy and safety in extending time to progression of prostate cancer in men diagnosed with low-risk, localized disease who are undergoing expectant management.

Those who may qualify are males between the ages of 50 and 80 who have biopsy-proven, low-risk localized prostate cancer and are active in expectant management within one year (biopsy must have been obtained within 6 months of screening) and have no history of another cancer within 5 years that could affect the diagnosis of prostate cancer.

The research site is in Albuquerque, N.M.

More information

Please see http://www.centerwatch.com/patient/studies/cat36.html.

-----

Diabetes - Type 2

Novartis Pharmaceutical Corp. is conducting research to determine the safety and effectiveness of adding the investigational drug vildagliptin to the metformin treatment of patients with diabetes.

This 24-week research study is for candidates between the ages of 18 and 78 who cannot control their type 2 diabetes with metformin (Glucophage ® ) tablets, diet and exercise.

Successful candidates for this study must not have a history of type 1 diabetes or any heart conditions such as heart attack, stroke, bypass surgery or heart failure. Research sites are located across the United States.

More information

Please see http://www.centerwatch.com/patient/studies/cat603.html.

-----

Copyright 2006 Thomson CenterWatch. All rights reserved.

Consumer News